Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
4.020
+0.280 (7.49%)
At close: Sep 26, 2025, 4:00 PM EDT
4.040
+0.020 (0.50%)
After-hours: Sep 26, 2025, 7:50 PM EDT

Unicycive Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
718230831-
Upgrade
Market Cap Growth
88.12%173.36%270.11%-73.58%--
Upgrade
Enterprise Value
495117113-
Upgrade
Last Close Price
4.027.948.685.4020.60-
Upgrade
PS Ratio
--44.688.57--
Upgrade
PB Ratio
3.4511.09-7.92-17.481.87-
Upgrade
P/TBV Ratio
4.3211.09--1.87-
Upgrade
EV/Sales Ratio
--24.771.40--
Upgrade
Debt / Equity Ratio
0.030.09-0.21-0.330.02-0.94
Upgrade
Asset Turnover
--0.080.09--
Upgrade
Quick Ratio
1.651.080.550.147.88-
Upgrade
Current Ratio
2.181.280.760.818.750.07
Upgrade
Return on Equity (ROE)
-131.87%-2028.11%--225.47%-145.04%-
Upgrade
Return on Assets (ROA)
-51.00%-87.54%-152.67%-104.65%-59.22%-1132.29%
Upgrade
Return on Capital (ROIC)
-78.05%-787.80%--136.93%-67.46%-
Upgrade
Earnings Yield
-44.36%-44.55%-101.28%-221.63%-32.48%-
Upgrade
FCF Yield
-46.75%-34.75%-60.67%-192.11%-18.79%-
Upgrade
Buyback Yield / Dilution
-209.65%-172.97%-62.98%-28.96%-37.37%-4.68%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q